PedAM
Pediatric Disease Annotations & Medicines
| Disease | postherpetic neuralgia |
| Symptom | C0423716|neuropathic pain |
| Sentences | 5 |
| PubMedID- 22454692 | We previously found that yokukansan clinically attenuates neuropathic pain due to postherpetic neuralgia, complex regional pain syndrome, and central cord syndrome and reported that yokukansan ameliorates neuropathic pain symptoms in patients 7. |
| PubMedID- 23602345 | A randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of gabapentin enacarbil in subjects with neuropathic pain associated with postherpetic neuralgia (pxn110748). |
| PubMedID- 22915873 | Several studies have provided evidence for the use of lmp in treating the neuropathic pain associated with postherpetic neuralgia.5–8 lmp has been included as the first-line treatment for localized peripheral neuropathic pain in many treatment recommendations for the us,9 europe,10 and latin america. |
| PubMedID- 20556211 | In 2 of the guidelines, topical lidocaine is recommended as a first-line treatment for patients with localized peripheral neuropathic pain (particularly in patients with postherpetic neuralgia and allodynia), whereas the other guideline considers topical lidocaine a second-line treatment. |
| PubMedID- 23235657 | Combining the classic neuropathic pain conditions of pdn, postherpetic neuralgia (phn) and post-stroke pain with fibromyalgia for second-tier evidence, in eight studies and 687 participants, there was a statistically significant benefit (risk ratio (rr) 2.3, 95% confidence interval (ci) 1.8 to 3.1) with a number needed to treat (nnt) of 4.6 (3.6 to 6.6). |
Page: 1